Fig. 5.
Freedom from leukemia of Balb/c mice injected with 1 × 105 cells of the B-lymphocytic leukemia cell line A20. Recipients received no further treatment (n = 10) or received TBI with a dose of 7.5 Gy followed by transplantation of hematopoietic stem cells 2 days after leukemia cell injection. The transplants were either syngeneic PBPCs (n = 22), allogeneic BM cells (n = 23), or allogeneic PBPCs (n = 26).
